In Alzheimer Disease (AD), possible biomarkers with diagnostic relevance have been identified, such as elevated lysosome-associated membrane protein 1 (LAMP1) and cathepsin D levels in plasma EVs [18], and low levels of EV-associated miRNA-193b in cerebrospinal fluid [19, 20]. This evidence concerns the gene LAMP1 and Alzheimer disease.